| Barbara Anne O'mara, MD | |
|
130 Fisher Rd, Berlin, VT 05602-9516 | |
| (802) 371-4100 | |
| Not Available |
| Full Name | Barbara Anne O'mara |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 130 Fisher Rd, Berlin, Vermont |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528162039 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fort Defiance Indian Hospital | Fort defiance, AZ | Hospital |
| Southwestern Vermont Medical Center | Bennington, VT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Fort Defiance Indian Hospital Board, Incorporation | 0941336697 | 144 |
News Archive
The worldwide safety experience of endoscopist-administered propofol sedation now exceeds 600,000 patients. The low rate of serious adverse events underscores the safety of nonanesthesiologist-administered propofol (NAAP) for gastrointestinal (GI) procedures, provided that it is administered by a team of individuals who have received training specific to the administration of propofol according to the "Position statement: nonanesthesiologist administration of propofol for GI endoscopy" issued by the four major gastroenterology and hepatology societies.
Bavarian Nordic A/S announced today that the company expects to file a New Drug Submission (NDS) for its third-generation smallpox vaccine, IMVAMUNE(R) with the Canadian Authorities, Health Canada in 2010. If successful, this would be the first marketing approval of IMVAMUNE(R).
HHS Secretary Kathleen Sebelius today announced the award of $17 million to fund projects to fight costly and dangerous health care-associated infections, or HAIs.
A case study from Intel and UCSD highlights the transformative collaboration between the school's bioengineering department and the Intel® Internet of Things (IoT).
Globus Medical, Inc., today announced that the Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the SECURE-C Cervical Artificial Disc. Clinical data from a 380 patient investigational device exemption (IDE) study demonstrate that SECURE-C is statistically superior to anterior cervical discectomy and fusion (ACDF) in terms of overall success, subsequent surgery at the index level, device-related adverse events, and patient satisfaction at 24 months.
› Verified 8 days ago
| Entity Name | The Fort Defiance Indian Hospital Board, Incorporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477876639 PECOS PAC ID: 0941336697 Enrollment ID: O20100429001153 |
News Archive
The worldwide safety experience of endoscopist-administered propofol sedation now exceeds 600,000 patients. The low rate of serious adverse events underscores the safety of nonanesthesiologist-administered propofol (NAAP) for gastrointestinal (GI) procedures, provided that it is administered by a team of individuals who have received training specific to the administration of propofol according to the "Position statement: nonanesthesiologist administration of propofol for GI endoscopy" issued by the four major gastroenterology and hepatology societies.
Bavarian Nordic A/S announced today that the company expects to file a New Drug Submission (NDS) for its third-generation smallpox vaccine, IMVAMUNE(R) with the Canadian Authorities, Health Canada in 2010. If successful, this would be the first marketing approval of IMVAMUNE(R).
HHS Secretary Kathleen Sebelius today announced the award of $17 million to fund projects to fight costly and dangerous health care-associated infections, or HAIs.
A case study from Intel and UCSD highlights the transformative collaboration between the school's bioengineering department and the Intel® Internet of Things (IoT).
Globus Medical, Inc., today announced that the Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the SECURE-C Cervical Artificial Disc. Clinical data from a 380 patient investigational device exemption (IDE) study demonstrate that SECURE-C is statistically superior to anterior cervical discectomy and fusion (ACDF) in terms of overall success, subsequent surgery at the index level, device-related adverse events, and patient satisfaction at 24 months.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Anne O'mara, MD 130 Fisher Rd, Berlin, VT 05602-9516 Ph: (802) 371-4100 | Barbara Anne O'mara, MD 130 Fisher Rd, Berlin, VT 05602-9516 Ph: (802) 371-4100 |
News Archive
The worldwide safety experience of endoscopist-administered propofol sedation now exceeds 600,000 patients. The low rate of serious adverse events underscores the safety of nonanesthesiologist-administered propofol (NAAP) for gastrointestinal (GI) procedures, provided that it is administered by a team of individuals who have received training specific to the administration of propofol according to the "Position statement: nonanesthesiologist administration of propofol for GI endoscopy" issued by the four major gastroenterology and hepatology societies.
Bavarian Nordic A/S announced today that the company expects to file a New Drug Submission (NDS) for its third-generation smallpox vaccine, IMVAMUNE(R) with the Canadian Authorities, Health Canada in 2010. If successful, this would be the first marketing approval of IMVAMUNE(R).
HHS Secretary Kathleen Sebelius today announced the award of $17 million to fund projects to fight costly and dangerous health care-associated infections, or HAIs.
A case study from Intel and UCSD highlights the transformative collaboration between the school's bioengineering department and the Intel® Internet of Things (IoT).
Globus Medical, Inc., today announced that the Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the SECURE-C Cervical Artificial Disc. Clinical data from a 380 patient investigational device exemption (IDE) study demonstrate that SECURE-C is statistically superior to anterior cervical discectomy and fusion (ACDF) in terms of overall success, subsequent surgery at the index level, device-related adverse events, and patient satisfaction at 24 months.
› Verified 8 days ago
Laura Allen Felsted, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd Ste 3, Mountainview Medical, Berlin, VT 05602 Phone: 802-225-5400 Fax: 802-225-5401 | |
Devika Singh, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Mob-b Suite 3, Berlin, VT 05602 Phone: 802-225-5400 Fax: 802-225-5401 | |
Brett Erdreich, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Berlin, VT 05602 Phone: 802-371-4100 | |
Dr. Joachim Georg Mueller, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Cardiology Mob-a Suite 2-1, Berlin, VT 05602 Phone: 802-225-5660 Fax: 802-229-9533 | |
Sarah E Swift, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 | |
Hannah Swayze-quinn, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 | |
Peter Alan Redford, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd, Hospitalist Program, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 |